Avivagen Inc. (CVE:VIV), a biotech stock, jumped after announcing that its partner in the Philippines has purchased a recurring, three-month supply of OxC-beta for Livestock
Sean Mason | August 16, 2017 | SmallCapPower
A purchase order from a Philippines partner injected a bit of buying interest into a biotech stock Wednesday. Here’s some small stocks making big moves on Wednesday, August 16, 2017 (as of 4 pm EST):
Avivagen Inc. (TSXV: VIV), a biotech stock, gained as much as 9% before closing up 4% to $1.20 on Wednesday after announcing that its partner in the Philippines, UNAHCO, has confirmed that it is scaling up, effective immediately, the commercial roll out of Avivagen’s OxC-beta for Livestock by purchasing a recurring, three-month supply at a time of OxC-beta for Livestock, for specific use in swine.
As well, shares of Atico Mining Corporation (TSXV: ATY) slipped 7% to $0.77 as the resource junior said there has been a temporary work stoppage at the El Roble mine in Colombia pending final inspection of the clean water discharge system.
Aveda Transportation and Energy Services Inc. (TSXV: AVE), meanwhile, reported a nearly 500% surge in its second-quarter revenue to a record $52.1 million, while its net loss for the quarter shrunk to $1.3 million from $9.8 million during the same period last year. Aveda stock moved up 36% to $0.455 following the announcement.
Finally, Berkwood Resources Ltd. (TSXV: BKR) shares rose 10% to $0.46 after the graphite explorer announced that drilling has begun on its Lac Gueret South Graphite Project located in Quebec.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: